ImmuPharma plc
IMM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£2,483 | -£2,922 | -£3,029 | -£6,587 |
| Dep. & Amort. | £64 | £38 | £118 | £114 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £88 | £140 | £160 | £616 |
| Change in WC | £69 | £470 | -£429 | £632 |
| Other Non-Cash | £494 | £910 | £833 | £392 |
| Operating Cash Flow | -£1,769 | -£1,364 | -£2,347 | -£4,833 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£2 | £0 | -£106 | -£51 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | -£75 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £1,364 | £0 | £0 | £0 |
| Other Inv. Act. | £6 | £189 | £29 | £1 |
| Investing Cash Flow | £1,294 | £189 | -£77 | -£50 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | -£723 |
| Stock Issued | £0 | £1,481 | £2,351 | £3,550 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £500 | -£759 | -£803 | -£2,125 |
| Financing Cash Flow | £500 | £722 | £1,548 | £702 |
| Forex Effect | £4 | -£6 | -£105 | -£31 |
| Net Chg. in Cash | £28 | -£459 | -£982 | -£4,213 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £208 | £668 | £1,649 | £5,862 |
| End Cash | £237 | £208 | £668 | £1,649 |
| Free Cash Flow | -£1,771 | -£1,364 | -£2,453 | -£4,884 |